Skip to main content
Barliz Waissengrin on Muck Rack

Barliz Waissengrin

As seen in: Wiley, Memory Studies, Journal of Clinical Pathology, The Lancet
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Barliz

Contact Barliz, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Artificial intelligence (AI) molecular analysis tool assists in rapid treatment decision in lung cancer: a case report

|
By Barliz Waissengrin, Alexandra Garasimov, Or Bainhoren, Ofer Merimsky
| Journal of Clinical Pathology Verified
Artificial intelligence (AI) molecular analysis tool assists in rapid treatment decision in lung cancer: a case report Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Open in Who Shared Issue with article?

Artificial intelligence (AI) molecular analysis tool assists in rapid treatment decision in lung cancer: a case report

|
By Barliz Waissengrin, Alexandra Garasimov, Or Bainhoren, Ofer Merimsky
| Journal of Clinical Pathology Verified
Barliz Waissengrin1,2, Alexandra Garasimov1, http://orcid.org/0000-0001-9910-5547Or Bainhoren1,2, Ofer Merimsky1,2, Sivan Shamai1,2, Ariel Erental2,3, Ido Wolf1,2, Dov Hershkovitz2,3 1Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel 2School of Medicine, Tel Aviv University, Tel Aviv, Israel 3Pathology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel Correspondence to Dr Barliz Waissengrin, Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel;...
Open in Who Shared Issue with article?

Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors

|
By Barliz Waissengrin, Abed Agbarya, Esraa Safadi
| The Lancet Verified
On Dec 20, 2020, the Israeli Ministry of Health launched a national COVID-19 vaccination campaign that aimed to rapidly vaccinate all high-risk individuals by the end of January, 2021, using the Pfizer BNT162b2 mRNA vaccine., 2 Harel A Israel's ambitious vaccine drive is set for success as Netanyahu seeks election campaign boost. Haaretz. Vaccines were readily available and free of charge.
Open in Who Shared Issue with article?
See all 6 articles